Benefits of Early Initiation of Biologic DMARDs in pJIA Arthritis & Rheumatology | October 2, 2025The early initiation of biologic disease-modifying anti-rheumatic drugs (DMARDs) may reduce the overall disease burden in patients with polyarticular juvenile idiopathic arthritis (pJIA), according to findings from Ringold et al.